Primary Site >> Colorectal Cancer

Gene >> MTCH1

Journal: Anticancer Res. 1996 Jul-Aug;16(4A):1805-11.
Title: Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-alpha and topoisomerase II alpha in prostate cancer.
Author: Lee, C H|Liu, M|Sie, K L|Lee, M S
PMID: 8712704
Journal: Histopathology. 1998 Jan;32(1):20-7.
Title: Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.
Author: Torenbeek, R|Lagendijk, J H|Van Diest, P J|Bril, H|van de Molengraft, F J|Meijer, C J
PMID: 9522212
Journal: Mol Cancer. 2006 May 18;5:20.
Title: Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
Author: De Angelis, Paula M|Svendsrud, Debbie H|Kravik, Katherine L|Stokke, Trond
PMID: 16709241
Journal: Anticancer Drugs. 2007 Jul;18(6):633-9.
Title: Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.
Author: Tang, Hua|Liu, Yuan-Jun|Liu, Min|Li, Xin
PMID: 17762391